REGEN-CoV for Treatment of COVID-19: Clinical & Billing Considerations for Home Infusion Therapy

Jeffrey Joseph, MD joined Regeneron Pharmaceuticals in March 2021 as an Associate Medical Director, Medical Affairs on the COVID-19 team, part of the General Medicine Franchise to support TN, NC, SC, and VA. Dr. Joseph has been a key contributor in helping to expand access to REGEN-COV throughout the region with the ambition of increasing patient access >span class="NormalTextRun SCXW27500930 BCX0">primary care reach which could drastically impact the course of the pandemic. Dr. Joseph has been in industry for 11 years. Prior roles included positions as Medical Science Liaison with DBV Technologies for NY Metro and Regional Medical Liaison with Novo Nordisk, Inc. for upstate NY. Upon embarking on an industry-focused career after medical training, Dr. Joseph previously spent several years supporting pharmaceutical Medical Affairs and marketing clients as a Medical Director in the medical communications space in New York City. His therapeutic focus, while diverse, has focused in the cardiometabolic and type two diabetes arena, immunology and food allergy, and now infectious disease. Dr. Joseph also has experience in organ and tissue donation having served in the procurement of human tissue for donation during and after medical school with the New York Organ Donor Network, now called LiveOnNY. Jeff holds a Doctor of Medicine degree from Ross University School of Medicine and a Bachelor of Science in biology and sports science from Tulane University in New Orleans.

Bill Noyes is the Senior Vice President of Reimbursement Policy at the National Home Infusion Association (NHIA). He joined NHIA in 2012 as Vice President of Health Information Policy, focusing on reimbursement and regulatory issues affecting providers' ability to do business and collect payment for their services. Noyes sits on four Medicare Contractor Advisory Councils and is the liaison to NHIA's reimbursement-focused committees. He also works closely with the NHIA government relations team to gain more meaningful Medicare coverage for home infusion. He served as Interim CEO of the associaiton from July 2018 to November 2018. Prior to joining NHIA, Noyes spent 20 years as Vice President of Operations for a multi-state home infusion provider where he was responsible for purchasing, distribution, facilities, revenue cycle management, and pharmacy operations.